免疫细胞介导的肠道微生物群和性结肠炎之间的因果关系:双向的双样本,介导门德尔随机化分析
Jinyin Xiao1,2, Xiajun Guo3, Youwei Lin2
1Department of Anorectal, The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China.
Frontiers in nutrition
|November 11, 2024
概括
这项研究揭示了肠道细菌和性结肠炎 (UC) 之间的因果关系,确定了保护或风险UC的特定微生物. 它强调了Mo MDSC上的CD11b作为这种关系中的关键免疫调解者.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 遗传流行病学 遗传流行病学
背景情况:
- 性结肠炎 (UC) 与肠道微生物群有关,但免疫细胞作为调解者的作用尚不清楚.
- 了解这些相互作用对于开发新的UC治疗方法至关重要.
研究的目的:
- 使用孟德尔随机化 (MR) 调查肠道微生物群和UC之间的因果关系.
- 探索免疫细胞在肠道微生物群-UC轴中的调解作用.
主要方法:
- 利用全基因组关联研究 (GWAS) 对肠道微生物群,免疫细胞和UC的数据.
- 使用两个样本的MR,贝叶斯加权MR (BWMR) 和反向MR来评估因果关系.
- 应用了两步式MRI来识别免疫细胞介质并量化其影响.
主要成果:
- 在20种肠道微生物和UC之间建立了因果关系;14种是保护性,6种是危险因素.
- 鉴定了26个免疫细胞媒介体,其中Mo MDSC上的CD11b与*Bifidobacterium bifidum* (p=0.0017) 有显著的关联.
- 发现CD11b在Mo MDSC上调解了*B. bifidum*和UC之间的影响的16.67%.
结论:
- 证实了特定肠道微生物群和UC之间的因果关系.
- 在Mo MDSC上的CD11b是*B. bifidum*和UC之间的重要免疫调解者.
- 这些发现为UC治疗提供了新的治疗点.
更多相关视频
05:28Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
2.1K
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
143
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
143
01:29Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120